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The presence of hepatitis B virus (HBV) DNA in 
extrahepatic tissues has been well documented. 
Whether HBV DNA can persist in extrahepatic 
tissues for long periods of time in the absence of 
replication in the liver has not been determined 
previously. Recently, two patients with end-
stage liver disease secondary to chronic active 
HBV were treated with baboon liver xenotrans-
plants as these animals are felt to be resistant to 
HBV infection. Multiple tissues from these two 
patients were examined for HBV DNA using 
polymerase chain reaction (peR). HBV DNA was 
not detectable in four of five samples of the liver 
xenografts. A positive signal was observed in a 
single assay for one sample, but this sample 
was not positive in subsequent assays. HBV DNA 
was detected in peripheral blood lymphocytes, 
spleen, kidney, bone marrow, pancreas, lymph 
node, heart and small intestine. The level of HBV 
DNA in these tissues was too low for the detec-
tion of HBV DNA replicative intermediates by 
Southern hybridization; thus, it could not be de-
termined whether the HBV DNA in these tissues 
represented actively replicating HBV in extrahe-
patic sites, integrated HBV sequences, HBV in 
infiltrating lymphocytes, or deposition of HBV 
immune complexes originating from the plasma. 
However, it is clear from this study that HBV DNA 
persisted in multiple tissues for 70 days after rep-
lication in the liver had ceased or at least was 
below the level of detection by peR. 
© 1995 Wiley-Liss,lnc. 
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INTRODUCTION 
The Hepadnaviridae family is comprised of human 
hepatitis B virus (HBV) and several closely related an-
imal viruses including duck hepatitis B virus (DHBV), 
© 1995 WILEY-LISS, INC. 
woodchuck hepatitis virus (WHY) and ground squirrel 
hepatitis virus (GSHV). All members of Hepadnaviri-
dae have a primary tropism for the liver. Extrahepatic 
replication of hepadnaviruses is well documented in 
animal models, but characterization of extrahepatic 
replication in HBV-infected humans has been more 
problematic. The detection of viral DNA in a tissue is 
insufficient evidence of replication, and replicative 
forms of viral DNA and viral RNA have not been con-
sistently observed, perhaps due to the low levels of nu-
cleic acids present in these organs. 
Recently, two baboon to human liver xenotransplan-
tations were undertaken on patients suffering from 
end-stage liver disease secondary to chronic HBV infec-
tions [Starzl et aI., 1993]. Xenotransplantation was 
undertaken, since allotransplantation of liver in HBV 
patients is associated with a poor prognosis largely be-
cause residual HBV in the recipient can infect the 
transplanted graft resulting in rapid liver destruction 
[Lake, 1991; Perrillo and Mason, 1993; Todo et aI., 
1991]. 
The mechanism of liver disease before transplanta-
tion is immunologically related, whereas the often 
rapid destruction of the transplanted organ is believed 
to result from the direct cytopathic effect of high levels 
of viral replication. Presumably, viral replication is el-
evated in transplant recipients due to immunosuppres-
sion. The use ofHBV hyperimmune globulin to prevent 
infection of the transplanted organ has been only par-
tially successful and may only delay infection of the 
transplanted liver. Whether infection of the trans-
planted organ is initiated by residual circulating virus 
derived originally from the liver or whether infectious 
virus from extrahepatic tissues is the source of infection 
has not been determined. The use of xenotransplants 
from a species not susceptible to HBV infection may 
overcome this obstacle. 
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In the present study, tissues from the two recipients 
of baboon liver transplants were examined to ascertain 
that HBV would not replicate in the baboon livers and 
to determine whether HBV DNA would persist in ex-
trahepatic tissues in the absence of replication in the 
liver. The results indicate that HBV DNA can persist 
for long periods of time in the absence of detectable 
replication in the liver. Longer periods of observation 
will be required to determine whether this procedure 
will eventually lead to the elimination of extrahepatic 
HBV DNA. However, the preliminary data from these 
short-term studies suggest that the procedure does 
overcome reinfection of the donor organ. 
MATERIALS AND METHODS 
Patients 
Patient 1 was a 35-year-old male with end-stage liver 
failure secondary to chronic HBV infection. The patient 
was also infected with human immunodeficiency virus 
(HIV) [Starzl et al., 1993] and had undergone a splenec-
tomy due to trauma several years prior to the trans-
plant. Patient 2 was a 62-year-old male with chronic 
active HBV infection. The HBV serology of the pa-
tients was as follows: HBV DNA positive by PCR (Fig. 
2), HBsAg-positive, anti-HBcAg-positive, and anti-
HBsAg-negative. Patient 1 was anti-HBeAg- and 
HBeAg-negative, while patient 2 was anti-HBeAg-neg-
ative and HBeAg-positive. Both patients were anti-
HCV- and delta virus-negative. Patient 1 was anti-
HAV-negative, while patient 2 was anti-HAV IgG-
positive, IgM-negative. The second patient received 
donor baboon bone marrow perioperatively [Starzl et 
al., 1994]. Patients were maintained on a four-drug 
immunosuppression therapy including FK506, pred-
nisone, prostaglandin and cyclophosphamide. Serum 
samples were obtained weekly, lymph node and liver 
biopsies were obtained at various times and the spleen 
of patient 2 was removed on day 15 post-transplanta-
tion. All other tissues were obtained at autopsy. 
Nucleic Acid Purification 
Serum samples (50 J-Ll) were mixed with an equal 
volume of TNES buffer (20 mM Tris, pH 7.4, 20 mM 
NaCl, 20 mM EDTA, 1% SDS), and tissue samples 
E~OMM mg) were homogenized by grinding in 200 f-LI of 
TNES. Samples were digested with 10 J-Ll of 5 mg/ml 
proteinase K for 2 hr at 65°C, were mixed with 1 f-LI of 10 
mg/ml tRNA and 10 J-Ll of3 M sodium acetate, and were 
extracted with phenol/chloroform/isoamyl alcohol and 
then chloroform/isoamyl alcohol. DNA was precipi-
tated with ethanol and resuspended in 50 f-Ll of water. 
DNA concentrations were estimated by the formula 
OD@260 x 50 = mg/ml and by examination of each 
sample by gel electrophoresis and ethidium bromide 
staining. 
Polymerase Chain Reaction and 
Southern Hybridization 
Primers for PCR amplification were chosen using the 
OLIGO program and were selected from a highly con-
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served domain overlapping the core gene such that all 
sequenced HBV isolates could be amplified with this set 
of primers. The forward primer, 5'-CCTTGGGTG-
GCTTTGGGGCA-3', spanned nucleotides 1884-1904, 
using the EcoRl site of the ayw sequence as nucleotide 
1, and the reverse primer, 5'-GGGCATTTGGTGGTC-
TATA-3', spanned nucleotides 2295-2274. DNA from 
either 10 J-LI of serum or 500 ng of DNA from tissue 
samples was analyzed by PCR amplification with 3.6 
min at 94°C for an initial denaturation step followed by 
35 cycles of 1.3 min at 94°C, 2 min at 55°C, and 3 min at 
72°C and a final step of 7 min at 72°C. Samples were 
analyzed by agarose gel electrophoresis and Southern 
hybridization with a 32P-Iabeled, random-primed HBV 
DNA probe. 
RESULTS 
Xenotransplant Patients 
Two patients have recently received baboon liver 
xenotransplants. Both patients had end-stage liver dis-
ease associated with chronic HBV infections and were 
not considered to be good candidates for human liver 
transplants. Baboon liver transplants were attempted, 
because the baboon liver is considered nonpermissive 
for HBV infection, and the use of the immunosuppres-
sive drug FK506 was expected to prevent rejection. In 
addition, HBIG was administered at the time of trans-
plants for both patients and was continued through the 
first week for patient 2 to facilitate clearance of resid-
ual virus. As a result, both patients were anti-HBsAg-
positive and HBsAg-negative throughout the course of 
the study. Patient 1 survived for 70 days, and the clini-
cal details of this case have been published previously 
[Starzl et al., IH93]. Patient 2 survived 27 days. Neither 
patient died due to rejection of the baboon liver, and no 
evidence of HBV replication in the baboon liver was 
observed by immunohistochemical staining for HBsAg 
or HBcAg lStarzl et aI., 1993]. An analysis of tissue 
samples from these individuals by PCR for HBV DNA 
permitted an examination of several issues. Presum-
ably, HBV would not replicate in the transplanted ba-
boon livers, but the issue of whether the HBV infection 
would resolve in the absence of replication in the liver 
was unknown. 
To optimize the detection of HBV DNA by poly-
merase chain reaction (PCR), primers were chosen, 
from the highly conserved core gene region (Fig. lA), 
that were capable of detecting all sequenced isolates of 
HBV. PCR conditions were optimized using cloned 
HBV DNA. The level of sensitivity varied between 10 
and 100 molecules following one round of 35 cycles of 
amplification and detection by Southern hybridization 
(Fig. IB). Purification of HBV DNA from an infectious 
chimpanzee plasma (X328) using the same protocol as 
to be used for clinical samples showed a positive signal 
at a 10-6 dilution (Fig. lC). Extrapolation of Southern 
blot data with this serum sample and cloned HBV DNA 
standards of known concentration estimated the 10-6 
dilution to contain four molecules of DNA. Thus, this 
method generally has a sensitivity ranging from 4 to 
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Fig. 1. Standardization ofPCR for HBV DNA. A: The region of the 
HBV genome being amplified is depicted including the nucleotide 
numbers spanning the open reading frame for the core gene. The 
forward and reverse primers are indicated by arrows below the core 
gene and the numbers indicate the 5' nucleotide of each primer. Prim-
ers were selected to amplify all sequenced strains of HBV. B: The 
sensitivity ofthe PCR amplification was evaluated with HBV plasmid 
DNA. Tenfold dilutions of plasmid DNA were amplified and PCR 
100 molecules in different experiments. The 10-4 and 
10-5 dilutions of the chimpanzee sera were included in 
all experiments as sensitivity controls. 
Examination of serial serum samples from patients 1 
and 2 revealed positive signals prior to transplant and 
intermittent signals thereafter. Of nine samples taken 
after transplant for patient 1, only the sample on day 31 
was positive (Fig. 2). Patient 2 was positive on day 
3 and 22 post-transplantation, but was negative on 
days 9 and 17 (Fig. 2). All positives were confirmed in at 
least two assays. Some positive samples were not posi-
tive in all assays, presumably because the level of 
RBV DNA in all of the samples was near the limits of 
detection in our assay, and thus stochastic variation 
would result in some samples being positive intermit-
tently. 
Analysis of DN A from multiple tissues revealed that 
most were strongly positive by peR. Each sample was 
run at 500 ng of DNA such that the level ofRBV DNA 
in each tissue could be directly compared. Peripheral 
blood lymphocytes (PBLs) from patient 1 were negative 
26 days prior to transplantation and positive 24 and 25 
days after transplantation (Fig. 3). PBLs for patient 2 
were only available 25 days post-transplantation and 
were negative at that time. For patient 1, a lymph node 
biopsy on day 11 was positive, while a liver biopsy sam-
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products were detected by agarose gel electrophoresis and Southern 
hybridization. C: The sensitivity of the extraction, purification and 
amplification of an HBV-positive chimpanzee (x328) plasma was ex-
amined. The number of molecules of HBV DNA in the plasma was 
estimated by comparison to HBV plasmid DNA of known concentra-
tion using Southern hybridization. The sensitivity of amplification 
ranges from 4 to 100 molecules. 
pIe on day 16 was negative. The DNA from liver tissue 
obtained from patient 1 at autopsy was negative, but 
due to extensive degradation of the cellular DNA, inter-
pretation of the analysis of this sample must be made 
with caution. Two kidney samples, a lymph node and 
heart tissue, taken at autopsy, were all positive for 
patient 1. A more extensive set of tissues was available 
from patient 2. Spleen tissue obtained at the time of 
splenectomy (day 15 after transplantation) was highly 
positive. A liver biopsy on day 12 and autopsy liver 
tissue (day 27) were negative. A liver biopsy from day 
24 was positive in a single assay, but was not positive in 
subsequent assays. Since we have demonstrated that 
baboons cannot be infected with RBV (unpublished 
data), and 4 of 5 liver samples from patients 1 and 2 
were peR-negative including a sample 3 days later at 
the time of autopsy, we assume that the day 24 liver 
biopsy may have been positive due to the presence of 
positive PBLs in that sample. Alternatively, since this 
sample was not positive in subsequent assays, it could 
represent peR contamination despite the extensive 
precautions to prevent contamination and the absence 
of contamination in the negative controls. Of tissue 
samples obtained from patient 2 at autopsy, lymph 
node, pancreas, kidney, bone marrow, and small intes-
tine were positive, while the liver was negative. 
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Fig. 2. PCR analysis of HBV DNA in serial serum samples from the two baboon liver recipients HBV 
DNA from serum samples was extracted, purified and amplified as described in Materials and Methods. 
PCR products were detected by agarose gel electrophoresis and Southern hybridization. The 10-4 and 
10' dilutions of plasma from chimpanzee x 328 were included as sensitivity controls and are the same 
dilutions as analyzed in Figure IC. 
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Fig. 3. PCR analysis of HBV DNA in tissue samples from the two 
baboon liver recipients. DNA was purified from various tissues as 
described in Materials and Methods and 500 ng of purified DNA was 
amplified by PCR. The PCR products were detected by agarose gel 
electrophoresis and Southern hybridization. The days post-transplan-
tation that PBL and biopsy tissues were obtained are indicated as well 
as the day post-transplantation that tissues were obtained at autopsy, 
DISCUSSION 
Due to the limited duration of the current study, it is 
not possible to determine conclusively whether baboon 
livers transplanted into humans infected chronically 
with RBV are resistant to RBV infection. One of five 
liver biopsies from humans that received baboon liver 
transplants was PeR-positive in a single assay. AI-
days 70 and 27 for lPatient 1 and 2, respectively. Two different kidney 
(Kd) samples were analyzed from patient 1. Multiple tissues were 
positive for HBV DNA with one of the five baboon liver samples being 
positive presumably from infiltrating lymphocytes. NC, negative con-
trol; PBL, peripheral blood lymphocytes; Lv, liver; Ln, lymph node; 
Kd, kidney; Ht, heart; Sp, spleen; Pn, pancreas; Bm, bone marrow and 
SI, small intestine. 
though it could be argued that the positive peR signal 
represents possible infection of the liver, it is more 
likely that the HBV DNA detected was present in lym-
phocytes_ Examination of this liver at autopsy by im-
munohistochemical staining failed to detect RBsAg or 
RBcAg in hepatocytes [Starzl et aI., 1993, 1994]. The 
level of DNA detected in this liver biopsy by peR was 
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too low to be detected by Southern hybridization (data 
not shown), and thus it is not possible to determine 
whether replication of HBV was occurring. The ex-
treme sensitivity of PCR to monitor infection should 
have allowed early detection of infection of the baboons 
livers. The PCR negativity offour of five liver samples 
is suggestive that the baboon livers were resistant to 
infection, but an increased survival time for the pa-
tients would be required to answer conclusively this 
question. 
HBV DNA persisted in multiple tissues in humans in 
the absence of detectable replication in the liver. The 
level ofHBV DNA in these tissues was also insufficient 
to detect by Southern hybridization; thus it was again 
impossible to determine whether HBV replication was 
occurring. Viral DNA has been demonstrated in multi-
ple tissues in hepadnavirus animal models and in HBV-
infected humans. In the duck, extrahepatic DHBV rep-
lication has been detected in the pancreas, spleen and 
kidney [Halpern et aI., 1986; Jilbert et aI., 1987; Ho-
soda et aI., 1990] with some evidence for replication in 
brain, lung, heart and intestine [Hosoda et aI., 1990 J. In 
the woodchuck, extrahepatic replication of WHY is de-
tected primarily in the spleen [Korba et aI., 1987]. 
WHY DNA present in peripheral blood lymphocytes is 
mostly nonreplicative forms; however, in vitro stimula-
tion ofPBLs from chronically infected woodchucks with 
lipopolysaccharide results in the appearance of replica-
tive forms of viral DNA [Korba et aI., 1988]. 
There are many reports on the detection of HBV nu-
cleic acids in PBLs using a variety of techniques includ-
ing Southern hybridization, in situ hybridization and 
polymerase chain reaction [Pontisso et aI., 1984; David-
son et aI., 1987; Lamelin and Trepo, 1990; Leung et aI., 
1994; Mason et aI., 1992; Hadchouel et aI., 19881. In 
many instances, replicative forms of HBV DNA were 
either absent IPontisso et aI., 1984; Davidson et aI., 
1987] or not definitively demonstrated. The HBV DNA 
in PBLs is presumably not derived from adherence of 
circulating virus, since HBV DNA can be detected in 
the PBLs of patients that have cleared serum HBV 
DNA or HBsAg lPontisso et aI., 1984; Leung et aI., 
1994; Mason et aI., 1992; Hadchouel et aI., 1988]. In 
other studies, HBV nucleic acids have been detected in 
multiple tissues [Mason et aI., 1993; Dejean et aI., 1984; 
Yoffe et aI., 1990] with some reports detecting such 
widespread distribution as to include lymph nodes, 
bone marrow, spleen, kidney, skin, colon, stomach, tes-
tes and periadrenal ganglia [Mason et aI., 1993]. It is 
not known whether these tissues are capable of sup-
porting the complete replication cycle and the produc-
tion of infectious virus and whether extrahepatic DNA 
would persist in the absence of hepatic replication. 
The PCR signal observed in extrahepatic tissues in 
this study could originate from several sources. It may 
represent replication ofHBV in cells of that organ. The 
DNA may reside within lymphocytes present in these 
organs, whether it is active in replication or not. The 
HBV DNA could be due to sequestered immune com-
plexes derived from preexisting plasma virus and the 
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injection ofHBIG. Inoculation of rhesus monkeys with 
a high dose of HBV apparently resulted in detection of 
carryover of the inoculum for a period of 3 months 
I Lazizi and Pillot, 1993]. Finally, the signal observed in 
various organs may not represent free viral DNA, but 
may be from integrated HBV DNA sequences as a con-
sequence of the long-term chronic infections. Thus, in 
the absence of definitive markers of replication, it is not 
possible to determine the origin ofthe HBV DNA in the 
various tissues. 
This study confirms the lack of detectable HBV DNA 
replication in the baboon liver. The lack of detectable 
HBV replication in the donor liver and the resistance of 
baboons to HBV infection (unpublished data) suggests 
that a maintenance regimen with HBIG is probably not 
required. The potential for detrimental effects accom-
panying the use of HBIG and the immune complexes 
derived from residual HBsAg and hepatitis B virions at 
the time of transplantation may be greater than any 
benefit derived from neutralization of the virus. Resid-
ual virus in the plasma should eventually be cleared, 
unless extrahepatic tissues are actually capable of sus-
taining an active HBV infection. The answer to this 
question will require longer-term survival for future 
patients receiving xenotransplants. 
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